Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Senior Management
Scientific Advisory Board
Corporate Governance
Programs
NYR-BI03
Myocardial Ischemia and Arrhythmia Control
Stroke
Traumatic Brain Injury
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
27-Apr-2020
Change of Director's Interest Notice - JM
22-Apr-2020
Appointment of New Chief Financial Officer
20-Apr-2020
Preclinical Program & Corporate Update Global Webinar
14-Apr-2020
Appendix 4C - March 2020 quarterly
6-Apr-2020
Nyrada Newsletter Released
16-Mar-2020
Update on Progress in Nyrada Programs
27-Feb-2020
Nyrada Inc. Corporate Presentation February 2020
25-Feb-2020
Appendix 4D and Half Year Accounts
11-Feb-2020
Significant advance in Nyrada PCSK9i program published
20-Jan-2020
Nyrada Inc - Chairman's letter to shareholders
Previous
1
2
3
4
5
6
7
8
Next
